Genetics, Genomics & Molecular Diagnostics News

The test is approved as a tool to identify which patients with a kind of ovarian cancer are likely to benefit most from Tesaro's Zejula (niraparib).

At the American College of Medical Genetics and Genomics annual meeting in Phoenix, WuXi presented results from a pilot study involving 190 individuals.

The proposed cut comes on the heels of a budget proposal that would reduce the NIH's fiscal year 2018 budget by 20 percent.

At the ACMG annual conference in Phoenix last week, several labs and companies discussed their efforts in healthy genome sequencing.

For the first time, the researchers also found a clear difference in risk factors for high-grade glioblastoma versus low-grade glioma.

The deal adds germline mutation information to the tumor sequencing, proteomic, and phosphoproteomic data Perthera currently uses to guide patient therapy.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.

This application reports a method to monitor the common systemic response to cancer. We spectrally quantified over 200 serum proteins, and most notably enriched for sub-populations of the protease inhibitor Alpha-1-Antitrypsin, which would not have been observable without the method. From this data, we solicit that protein markers from categorical panels can distinguish a cancer serum phenotype at very early stages, possibly even before presentation of any clinical evidence.